Patent · US Active

Reactive oxygen species scavengers and use for treating diseases

US10889572B2 · kind B2 · utility

34Cited by
2References
25Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 26, 2020
Grant dateJan 12, 2021
Priority date
Expiry dateFeb 26, 2040

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A compound of Formula (I), pharmaceutically acceptable salts thereof, and individual enantiomers or diastereomers thereof. Compositions and methods useful for treatment or suppression of diseases, developmental delays and symptoms related to oxidative stress.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.